Female lab worker wearing safety glasses in profile in a laboratory

Manufacturing Expertise Protein-Based Vaccine

Protein-based vaccines require reliable antigen expression, structural integrity, and scalable production to support clinical development and broader supply. Avid supports vaccine candidates through disciplined mammalian cell culture development and CGMP manufacturing aligned with regulatory expectations.

Overview

Accelerating Protein-Based Vaccine
Development with Proven Expertise

Key Development & Manufacturing Considerations

  • Protein integrity
  • Protein stability
  • Product yield
  • Purification efficiency
  • Scalable production

How Avid Supports Vaccine Programs

  • Process development and optimization
  • Clinical CGMP manufacturing
  • Analytical support
  • Platform-based scale-up

Learn More

Protein-Based Vaccine FAQs

Through defined process development, clinical manufacturing, and validated scale-up strategies.

Mammalian expression systems are commonly used to ensure proper protein folding, post-translational modifications and antigen quality.

Connect with our team to discuss development timelines, manufacturing strategy, and scalable CGMP production.